ANGPTL3 diminishes the resistance of ovarian cancer to paclitaxel by blocking the PI3K-AKT-mTOR signaling pathway

Dandan Wu(Fujian Medical University), Meiqin Xiao(Fujian Medical University)
Cited by 2


Related Papers